Prospective observational study to establish predictors of glyburide success in women with gestational diabetes mellitus

被引:70
作者
Chmait R. [1 ]
Dinise T. [2 ]
Moore T. [1 ]
机构
[1] Division of Reproductive Medicine, University of California, San Diego, CA 92103
[2] School of Medicine, University of California, San Diego, CA 92103
关键词
D O I
10.1038/sj.jp.7211147
中图分类号
学科分类号
摘要
Objective: To establish parameters associated with therapeutic success in gestational diabetics treated with glyburide. Study design: A total of 69 gestational diabetics who failed dietary therapy were treated with glyburide. Inadequate glycemic control on maximum dose glyburide (10 mg b.i.d.) was considered treatment failure. The glyburide failure rate was calculated and factors that might predict success with glyburide were analyzed between the success and failure groups using χ2 or Student's t-tests. Results: The glyburide failure rate was 18.8%. Gestational age at glyburide initiation (p<0.01), pretreatment fasting blood sugars (p<0.001), and 1-hour postprandial values (p<0.001) were the only statistically significant factors between the two groups. Glyburide success was predicted if dietary failure occurred after 30 weeks, or fasting blood sugars were <110 mg/dl and 1-hour postprandials were <140 mg/dl (sensitivity 98%, specificity 65%). Conclusion: Gestational diabetics who fail dietary therapy after 30 weeks gestation or have fasting blood sugars <110 mg/dl and 1-hour postprandials <140 mg/dl do well on glyburide therapy. © 2004 Nature Puhlishing Group. All rights reserved.
引用
收藏
页码:617 / 622
页数:5
相关论文
共 9 条
[1]  
Obstet. Gynecol., 98, pp. 525-538, (2001)
[2]  
Kemball M.L., McIver C., Milner R.D., Nourse C.H., Schiff D., Tiernan J.R., Neonatal hypoglycaemia in infants of diabetic mothers given sulphonylurea drugs in pregnancy, Arch. Dis. Child, 45, pp. 696-701, (1970)
[3]  
Zucker P., Simon G., Prolonged symptomatic neonatal hypoglycemia associated with maternal chlorpropamide therapy, Pediatrics, 42, pp. 824-825, (1968)
[4]  
Farquhar J.W., Isles T.E., Hypoglycemia in newborn infants of normal and diabetic mothers, S. Afr. Med. J., 42, pp. 237-245, (1968)
[5]  
Elliott B.D., Langer O., Schenker S., Johnson R.F., Insignificant transfer of glyburide occurs across the human placenta, Am. J. Obstet. Gynecol., 165, pp. 807-812, (1991)
[6]  
Elliott B.D., Schenker S., Langer O., Johnson R., Prihoda T., Comparative placental transport of oral hypoglycemic agents in humans: A model of human placental drug transfer, Am. J. Obstet. Gynecol., 171, pp. 653-660, (1994)
[7]  
Langer O., Conway D.L., Berkus M.D., Xenakis E.M., Gonzales O., A comparison of glyburide and insulin in women with gestational diabetes mellitus, New Engl. J. Med., 343, pp. 1134-1138, (2000)
[8]  
Carpenter M.W., Coustan D.R., Criteria for screening test for gestational diabetes, Am. J. Obstet. Gynecol., 144, pp. 768-773, (1982)
[9]  
Sweet success: Guidelines for care, (2001)